Risk Factors of CJC-1295 CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analogue, has been investigated as a stimulant of GH and IGF-I secretion in healthy adults, who tolerated it well at doses of 30 or 60 microg/kg, although at 100 micro g/kg adverse reactions (mainly gastrointestinal) proved more frequent
Re-verify math protocols before administration
There was a significant improvement overall in the groups treated with magnesium oxide and senna (68.3% and 69.2%, respectively) compared with placebo (11.7%)
Ohkusa T, Koido S, Nishikawa Y, et al
In Part 1, The Mother of All Antioxidants, we explained the importance of maintaining a healthy ratio of reduced-to-oxidized glutathione, presented common illnesses that arise when imbalances are left untreated, explained the benefits of reduced glutathione (GSH), and revealed the risks of self-medicating with over-the-counter GSH supplements
L-carnitine enhances resistance to oxidative stress by reducing DNA damage in Ataxia telangiectasia